Startseite Sphingolipids in inflammatory hypoxia
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Sphingolipids in inflammatory hypoxia

  • Ulrike G. Glaser und Joachim Fandrey EMAIL logo
Veröffentlicht/Copyright: 19. Juni 2018

Abstract

Hypoxia due to rapid tumor growth with impaired neovascularization and inflammation resulting from immune cell activation are hallmarks of cancer. Hypoxia-inducible factors control transcriptional adaptation in response to low oxygen conditions, both in tumor and immune cells. In addition, sphingolipids become increasingly recognized as important cell mediators in tumor and inflammatory hypoxia. Recent studies have identified acid sphingomyelinase (ASM), a central enzyme in the sphingolipid metabolism, as a regulator of several types of stress stimuli pathways and an important player in the tumor microenvironment. Therefore, this review will address the connection between the hypoxic response and the ASM/ceramide system in the context of inflammatory hypoxia.

Award Identifier / Grant number: GRK 2098

Funding statement: Deutsche Forschungsgemeinschaft, Funder Id: 10.13039/501100001659, Grant Number: GRK 2098.

References

Anelli, V., Gault, C.R., Cheng, A.B., and Obeid, L.M. (2008). Sphingosine kinase 1 is up-regulated during hypoxia in U87MG glioma cells: role of hypoxia-inducible factors 1 and 2. J. Biol. Chem. 283, 3365–3375.10.1074/jbc.M708241200Suche in Google Scholar

Basnakian, A.G., Ueda, N., Hong, X., Galitovsky, V.E., Yin, X., and Shah, S.V. (2005). Ceramide synthase is essential for endonuclease-mediated death of renal tubular epithelial cells induced by hypoxia-reoxygenation. Am. J. Physiol. Renal Physiol. 288, F308–F314.10.1152/ajprenal.00204.2004Suche in Google Scholar

Cuvillier, O. and Ader, I. (2011). Hypoxia-inducible factors and sphingosine 1-phosphate signaling. Anticancer Agents Med. Chem. 11, 854–862.10.2174/187152011797655050Suche in Google Scholar

Devlin, C.M., Lahm, T., Hubbard, W.C., Van Demark, M., Wang, K.C., Wu, X., Bielawska, A., Obeid, L.M., Ivan, M., and Petrache, I. (2011). Dihydroceramide-based response to hypoxia. J. Biol. Chem. 286, 38069–38078.10.1074/jbc.M111.297994Suche in Google Scholar

Eales, K.L., Hollinshead, K.E.R., and Tennant, D.A. (2016). Hypoxia and metabolic adaptation of cancer cells. Oncogenesis 5, 1–8.10.1038/oncsis.2015.50Suche in Google Scholar

Frede, S., Berchner-Pfannschmidt, U., and Fandrey, J. (2007). Regulation of hypoxia-inducible factors during inflammation. Methods Enzymol. 435, 405–419.10.1016/S0076-6879(07)35021-0Suche in Google Scholar

Garcia-Barros, M., Paris, F., Cordon-Cardo, C., Lyden, D., Rafii, S., Haimovitz-Friedman, A., Fuks, Z., and Kolesnick, R. (2003). Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 300, 1155–1159.10.1126/science.1082504Suche in Google Scholar PubMed

Garcia-Barros, M., Lacorazza, D., Petrie, H., Haimovitz-Friedman, A., Cardon-Cardo, C., Nimer, S., Fuks, Z., and Kolesnick, R. (2004). Host acid sphingomyelinase regulates microvascular function not tumour immunity. Cancer Res. 64, 8285–8291.10.1158/0008-5472.CAN-04-2715Suche in Google Scholar PubMed

Gordan, J.D., Thompson, C.B., and Simon, M.C. (2007). HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation. Cancer Cell 12, 108–113.10.1016/j.ccr.2007.07.006Suche in Google Scholar PubMed PubMed Central

Hait, N.C., Oskeritzian, C.A., Paugh, S.W., Milstien, S., and Spiegel, S. (2006). Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases. Biochim. Biophys. Acta Biomembr. 1758, 2016–2026.10.1016/j.bbamem.2006.08.007Suche in Google Scholar PubMed

Hanahan, D. and Weinberg, R.A. (2011). Hallmarks of cancer: the next generation. Cell 144, 646–674.10.1016/j.cell.2011.02.013Suche in Google Scholar PubMed

Jin, J., Hou, Q., Mullen, T.D., Zeidan, Y.H., Bielawski, J., Kraveka, J.M., Bielawska, A., Obeid, L.M., Hannun, Y.A., and Hsu, Y.T. (2008). Ceramide generated by sphingomyelin hydrolysis and the salvage pathway is involved in hypoxia/reoxygenation-induced bax redistribution to mitochondria in NT-2 cells. J. Biol. Chem. 283, 26509–26517.10.1074/jbc.M801597200Suche in Google Scholar PubMed PubMed Central

Kachler, K., Bailer, M., Heim, L., Schumacher, F., Reichel, M., Holzinger, C.D., Trump, S., Mittler, S., Monti, J., Trufa, D.I., et al. (2017). Enhanced acid sphingomyelinase activity drives immune evasion and tumor growth in non–small cell lung carcinoma. Cancer Res. 77, 5963–5976.10.1158/0008-5472.CAN-16-3313Suche in Google Scholar PubMed

Klevstig, M., Ståhlman, M., Lundqvist, A., Scharin Täng, M., Fogelstrand, P., Adiels, M., Andersson, L., Kolesnick, R., Jeppsson, A., Borén, J., et al. (2016). Targeting acid sphingomyelinase reduces cardiac ceramide accumulation in the post-ischemic heart. J. Mol. Cell. Cardiol. 93, 69–72.10.1016/j.yjmcc.2016.02.019Suche in Google Scholar PubMed PubMed Central

Klutzny, S., Lesche, R., Keck, M., Kaulfuss, S., Schlicker, A., Christian, S., Sperl, C., Neuhaus, R., Mowat, J., Steckel, M., et al. (2017). Functional inhibition of acid sphingomyelinase by Fluphenazine triggers hypoxia-specific tumor cell death. Cell Death Dis. 8, 1–15.10.1038/cddis.2017.130Suche in Google Scholar PubMed PubMed Central

Kornhuber, J., Tripal, P., Gulbins, E., and Muehlbacher, M. (2013). Functional inhibitors of acid sphingomyelinase (FIASMAs). In: Sphingolipids: Basic Science and Drug Development, E. Gulbins and I. Petrache, eds. (Vienna: Springer Vienna), pp. 169–186.10.1007/978-3-7091-1368-4_9Suche in Google Scholar PubMed

Larsson, T., Drevinge, C., Karlsson, L.O., Sta, M., Levin, M.C., Sundelin, J.P., Grip, L., Andersson, L., and Bore, J. (2013). Cholesteryl esters accumulate in the heart in a porcine model of ischemia and reperfusion. PLoS One 8, 2–9.10.1371/journal.pone.0061942Suche in Google Scholar

MacEyka, M. and Spiegel, S. (2014). Sphingolipid metabolites in inflammatory disease. Nature 510, 58–67.10.1038/nature13475Suche in Google Scholar PubMed PubMed Central

Opreanu, M., Tikhonenko, M., Bozack, S., Lydic, T.A., Reid, G.E., McSorley, K.M., Sochacki, A., Perez, G.I., Esselman, W.J., Kern, T., et al. (2011). The unconventional role of acid sphingomyelinase in regulation of retinal microangiopathy in diabetic human and animal models. Diabetes 60, 2370–2378.10.2337/db10-0550Suche in Google Scholar PubMed PubMed Central

Osawa, Y., Suetsugu, A., Matsushima-nishiwaki, R., Yasuda, I., Saibara, T., Moriwaki, H., Seishima, M., and Kozawa, O. (2013). Liver acid sphingomyelinase inhibits growth of metastatic colon cancer. J. Clin. Invest. 123, 834–843.10.1172/JCI65188Suche in Google Scholar PubMed PubMed Central

Pereira, E.R., Frudd, K., Awad, W., and Hendershot, L.M. (2014). Endoplasmic reticulum (ER) stress and hypoxia response pathways interact to potentiate hypoxia-inducible factor 1 (HIF-1) transcriptional activity on targets like vascular endothelial growth factor (VEGF). J. Biol. Chem. 289, 3352–3364.10.1074/jbc.M113.507194Suche in Google Scholar PubMed PubMed Central

Schito, L. and Semenza, G.L. (2016). Hypoxia-inducible factors: master regulators of cancer progression. Trends Cancer 2, 758–770.10.1016/j.trecan.2016.10.016Suche in Google Scholar

Schnitzer, S.E., Weigert, A., Zhou, J., and Brüne, B. (2009). Hypoxia enhances sphingosine kinase 2 activity and provokes sphingosine-1-phosphate-mediated chemoresistance in A549 lung cancer cells. Mol. Cancer Res. 7, 393–401.10.1158/1541-7786.MCR-08-0156Suche in Google Scholar

Schwalm, S., Döll, F., Römer, I., Bubnova, S., Pfeilschifter, J., and Huwiler, A. (2008). Sphingosine kinase-1 is a hypoxia-regulated gene that stimulates migration of human endothelial cells. Biochem. Biophys. Res. Commun. 368, 1020–1025.10.1016/j.bbrc.2008.01.132Suche in Google Scholar

Smith, E.L. and Schuchman, E.H. (2008a). The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases. FASEB J. 22, 3419–3431.10.1096/fj.08-108043Suche in Google Scholar

Smith, E.L. and Schuchman, E.H. (2008b). Acid sphingomyelinase overexpression enhances the antineoplastic effects of irradiation in vitro and in vivo. Mol. Ther. 16, 1565–1571.10.1038/mt.2008.145Suche in Google Scholar

Stiban, J. and Perera, M. (2015). Very long chain ceramides interfere with C16-ceramide-induced channel formation: a plausible mechanism for regulating the initiation of intrinsic apoptosis. Biochim. Biophys. Acta Biomembr. 1848, 561–567.10.1016/j.bbamem.2014.11.018Suche in Google Scholar

Werno, C., Menrad, H., Weigert, A., Dehne, N., Goerdt, S., Schledzewski, K., Kzhyshkowska, J., and Brüne, B. (2010). Knockout of HIF-1a in tumor-associated macrophages enhances M2 polarization and attenuates their pro-angiogenic responses. Carcinogenesis 31, 1863–1872.10.1093/carcin/bgq088Suche in Google Scholar

Yun, J.K. and Kester, M. (2002). Regulatory role of sphingomyelin metabolites in hypoxia-induced vascular smooth muscle cell proliferation. Arch. Biochem. Biophys. 408, 78–86.10.1016/S0003-9861(02)00526-XSuche in Google Scholar

Zhu, Q., Lin, L., Cheng, Q., Xu, Q., Zhang, J., Tomlinson, S., Jin, J., Chen, X., and He, S. (2012). The role of acid sphingomyelinase and caspase 5 in hypoxia-induced HuR cleavage and subsequent apoptosis in hepatocytes. Biochim. Biophys. Acta 1821, 1453–1461.10.1016/j.bbalip.2012.08.005Suche in Google Scholar PubMed

Received: 2018-02-28
Accepted: 2018-05-04
Published Online: 2018-06-19
Published in Print: 2018-09-25

©2018 Walter de Gruyter GmbH, Berlin/Boston

Heruntergeladen am 6.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/hsz-2018-0173/pdf
Button zum nach oben scrollen